CADAP 1, the first phase of the CADAP Programme (January 2001- December 2004), supported the following projects:

• Airport Control: procurement of drug control equipment and training to four major airports in the region;
• NADIN (National Drug Abuse Information Print): aimed at providing beneficiary countries with the means to carry out epidemiological assessments on drug abuse;
• ADMIT: Anti- Drug Measures in Tajikistan supported the development of the new drug control authority (DCA) in Tajikistan;
• EUDROCA: launched a coordination office located at the EC Delegation in Almaty from January 2001, now moved to Bishkek;

CADAP 2 (April 2004- December 2006) comprised the following projects:

• Legal assistance to reform drug legislation in line with European and international standards;
• Strengthening of law enforcement drug control capacities at airports, seaports and land borders;
• Development of national intelligence analysis and forensic laboratory capacities;
• Establishment of a model prison regime for drug-addicted prisoners to inhibit transmission of HIV/AIDS;
• Support to regional coordination office located in Bishkek, Kyrgyzstan;

CADAP 3 (October 2004- December 2007) covered the following projects:

• Reinforcement of drug control capacities at the border;
• Strengthening of regional forensic capacities;
• Raising of public awareness on the danger of drug consumption;
• Strengthening of regional cooperation and donor coordination;

The on-going Programme phase CADAP 4 (January 2007- December 2008) includes the following projects:

• Drug epidemiology to establish a sustained capacity to analyses drug related data based on EMCDDA (European Monitoring Center on Drug and Drug Addition) guidelines;
• Prevention of drug use in Prison: to offer treatment- rehabilitation services to inmates in prisons;
• Drug profiling at airports and railways: to encourage fight against drug and precursors trafficking based in intelligence and inter-agency cooperation;
• Prevention campaign in the media: to inform to population of the health- risks of drug use (including HIV infection)

The views expressed on this website do not necessarily reflect those of the United Nations, the United Nations Development Programme, its programmes/projects or governments.  The designations employed do not imply the expression of any opinion whatsoever concerning the legal status of any country, territory or area, or its frontiers or boundaries.